AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2018
Feb 9, 2018
284_dirs_2018-02-09_e2796634-6c8b-4e84-8618-2bf8b21a3dfb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-02-09
Reporting Person: WEEKS WENDELL P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-09 | Common Stock | M | 5000.0000 | $38.0400 | Acquired | 5100.0000 | Direct |
| 2018-02-09 | Common Stock | S | 5000.0000 | $53.5666 | Disposed | 100.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-09 | Stock Option (right to buy) | $38.0400 | M | 5000.0000 | Disposed | 2018-04-29 | Common Stock (5000.0000) | Direct |
Footnotes
F1: The option became exercisable in equal installments on 4/30/2009, 4/30/2010 and 4/30/2011.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8